Sg3 Management, LLC Bio N Tech Se Transaction History

Sg3 Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $852,696 - $1.34 Million	7,200 New	7,200 $1.08 Million
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $1.97 Million - $2.98 Million	-16,000 Reduced 84.21%	3,000 $447,000
Q1 2022 May 16, 2022	BUY	$126.25 - $231.85 $2.4 Million - $4.41 Million	19,000 New	19,000 $3.24 Million
Q2 2021 Aug 16, 2021	SELL	$113.32 - $241.49 $113,320 - $241,490	-1,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$85.73 - $119.5 $685,840 - $956,000	-8,000 Reduced 88.89%	1,000 $109,000
Q4 2020 Feb 16, 2021	BUY	$72.71 - $129.54 $654,390 - $1.17 Million	9,000 New	9,000 $734,000

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $29.3B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.